Vanderbilt-Zambia Innovations in Global Health Technologies
Overview
Investigators will evaluate approaches using magnetic bead capture, isolation, and surface tension valve transfer of biomarkers to process capillary blood in order to improve the sensitivity of already approved Rapid Diagnostic Tests (RDTs) for detection of human malaria infection. Results will be compared to those obtained using unenhanced capillary blood specimens directly applied to approved malaria RDTs. Participants seeking care for possible malaria in Zambia will be recruited to enroll in the study.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: February 2019
Interventions
- Other: mBEADS
- Evaluate approaches using magnetic bead capture, isolation, and surface tension valve transfer of biomarkers to improve the sensitivity of already approved malaria RDTs.
Clinical Trial Outcome Measures
Primary Measures
- Enhancement of malaria RDT to detect low levels of P falciparum parasites
- Time Frame: 5 years
- The expected outcome of this research project is to enhance the ability of standard malaria RDTs to detect low levels of Plasmodium falciparum malaria in human capillary blood.
Participating in This Clinical Trial
Inclusion Criteria
- Individuals giving written informed consent for themselves – Children under the age of 18 for whom a parent or guardian can give consent – Individuals seeking care or treatment of suspected or possible malaria – Individuals being screened as a contact of someone with recent malaria – Other individuals willing to have their blood tested for malaria Exclusion Criteria:
- Anyone over 18 unwilling or unable to provide informed consent – Anyone under 18 who does not have a parent or guardian to give consent – Anyone between the age of 12 and 18 who does not give assent
Gender Eligibility: All
Minimum Age: 6 Months
Maximum Age: 85 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Macha Research Trust, Zambia
- Collaborator
- Vanderbilt University
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.